Wyeth Trecator SC Shortage
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth's tuberculosis treatment Trecator SC (ethionamide) is in shortage due to manufacturing issues, according to FDA's Center for Drug Evaluation & Research drug shortages website Jan. 28 update
You may also be interested in...
Wyeth Trecator SC Reformulation Warrants "Dear Doctor" Letter
Patients switching to the film-coated Trecator from the old suger-coated tablets should be re-titrated to avoid intolerance to the treatment, the letter says. Normal distribution of the product has resumed after shortage.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.